胃内酸性,细菌,化物和N-化物化合物在西米提丁治疗前,期间和之后
在健康个体中,西米蒂丁治疗没有改变胃细菌或N-酸化合物水平. 这项研究没有发现证据表明cimetidine使用与通过这些因素增加胃癌风险有关.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 齐米提丁是一种用于减少胃酸的药物.
- 人们担心酸性减少与胃癌风险增加之间存在潜在的联系.
- N-nitroso化合物是胃中发现的潜在致癌物质.
研究的目的:
- 为了研究cimetidine治疗对胃内细菌数量,物种,酸盐和N-nitroso化合物度的影响.
- 评估cimetidine是否通过提高N-nitroso化合物水平增加胃癌的风险.
主要方法:
- 八名健康受试者参与了这项研究.
- 在24小时内,每小时或每半小时收集和分析胃内样本.
- 在西米蒂丁治疗过程之前,期间和之后进行了测量.
主要成果:
- 在胃内细菌数量,物种,酸盐或N-酸盐化合物度上没有明显的差异被观察到,这是由于西米蒂丁治疗.
- 细菌数量和亚酸盐度表现出随着pH值的上升而增加的趋势.
- N-nitroso化合物度与pH值变化或西米蒂丁治疗没有相关性.
结论:
- 该研究没有发现证据表明cimetidine治疗会增加胃内N-nitroso化合物度.
- 目前的研究结果不支持cimetidine使用与由N-nitroso化合物介导的胃癌风险增加之间的联系.
更多相关视频
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
